Gα(s)-Induced Neurodegeneration inCaenorhabditis elegans

od Berger, Allison J., Hart, Anne C., Kaplan, Joshua M.
izdano v J Neurosci (1998)

Regulation of T cell receptor complex-mediated signaling by ubiquitin and ubiquitin-like modifications

od Friend, Samantha F, Deason-Towne, Francina, Peterson, Lisa K, Berger, Allison J, Dragone, Leonard L
izdano v Am J Clin Exp Immunol (2014)

Insulin-Like Growth Factor-Binding Protein 3 Expression Increases during Immortalization of Cervical Keratinocytes by Human Papillomavirus Type 16 E6 and E7 Proteins

od Berger, Allison J., Baege, Astrid, Guillemette, Tracy, Deeds, James, Meyer, Ron, Disbrow, Gary, Schlegel, Richard, Schlegel, Robert
Izdano 2002

Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cells

od Tian, Ze, Zhao, Jian-jun, Tai, Yu-Tzu, Amin, Samir B., Hu, Yiguo, Berger, Allison J., Richardson, Paul, Chauhan, Dharminder, Anderson, Kenneth C.
Izdano 2012

The Discovery of a Reciprocal Relationship between Tyrosine-Kinase Signaling and Cullin Neddylation

od Friend, Samantha F., Peterson, Lisa K., Treacy, Eric, Stefanski, Adrianne L., Sosinowski, Tomasz, Pennock, Nathan D., Berger, Allison J., Winn, Virginia D., Dragone, Leonard L.
Izdano 2013

Overcoming platinum resistance in preclinical models of ovarian cancer using the neddylation inhibitor MLN4924

od Jazaeri, Amir A., Shibata, Etsuko, Park, Jonghoon, Bryant, Jennifer L., Conaway, Mark R., Modesitt, Susan C., Smith, Peter G., Milhollen, Michael A., Berger, Allison J., Dutta, Anindya
Izdano 2013

The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR

od Zhou, Liang, Chen, Shuang, Zhang, Yu, Kmieciak, Maciej, Leng, Yun, Li, Lihong, Lin, Hui, Rizzo, Kathryn A., Dumur, Catherine I., Ferreira-Gonzalez, Andrea, Rahmani, Mohamed, Povirk, Lawrence, Chalasani, Sri, Berger, Allison J., Dai, Yun, Grant, Steven
izdano v Blood (2016)

Phase 1 study of ixazomib, an investigational proteasome inhibitor, in advanced non-hematologic malignancies

od Smith, David C., Kalebic, Thea, Infante, Jeffrey R., Siu, Lillian L., Sullivan, Daniel, Vlahovic, Gordana, Kauh, John S., Gao, Feng, Berger, Allison J., Tirrell, Stephen, Gupta, Neeraj, Di Bacco, Alessandra, Berg, Deborah, Liu, Guohui, Lin, Jianchang, Hui, Ai-Min, Thompson, John A.
izdano v Invest New Drugs (2015)

KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism

od Chattopadhyay, Nibedita, Berger, Allison J., Koenig, Erik, Bannerman, Bret, Garnsey, James, Bernard, Hugues, Hales, Paul, Maldonado Lopez, Angel, Yang, Yu, Donelan, Jill, Jordan, Kristen, Tirrell, Stephen, Stringer, Bradley, Xia, Cindy, Hather, Greg, Galvin, Katherine, Manfredi, Mark, Rhodes, Nelson, Amidon, Ben
izdano v PLoS One (2015)

Phase I Study of the Novel Investigational NEDD8-activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/refractory Multiple Myeloma or Lymphoma

od Shah, Jatin J., Jakubowiak, Andrzej J., O’Connor, Owen A., Orlowski, Robert Z., Harvey, R. Donald, Smith, Mitchell R., Lebovic, Daniel, Diefenbach, Catherine, Kelly, Kevin, Hua, Zhaowei, Berger, Allison J., Mulligan, George, Faessel, Helene, Tirrell, Stephen, Dezube, Bruce J., Lonial, Sagar
izdano v Clin Cancer Res (2015)

Antitumor Activity of the Investigational Proteasome Inhibitor MLN9708 in Mouse Models of B-cell and Plasma Cell Malignancies

od Lee, Edmund C., Fitzgerald, Michael, Bannerman, Bret, Donelan, Jill, Bano, Kristen, Terkelsen, Jennifer, Bradley, Daniel P., Subakan, Ozlem, Silva, Matthew D., Liu, Ray, Pickard, Michael, Li, Zhi, Tayber, Olga, Li, Ping, Hales, Paul, Carsillo, Mary, Neppalli, Vishala T., Berger, Allison J., Kupperman, Erik, Manfredi, Mark, Bolen, Joseph B., Van Ness, Brian, Janz, Siegfried
Izdano 2011